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Objective. To determine if increasing variability of blood pressure influences determination of cerebral autoregulation. Methods.
A prospective observational study was performed at the ICU of a university hospital in the Netherlands. 13 comatose patients
after cardiac arrest underwent baseline and intervention (tilting of bed) measurements. Mean flow velocity (MFV) in the middle
cerebral artery andmean arterial pressure (MAP) weremeasured. Coefficient of variation (CV) was used as a standardizedmeasure
of dispersion in the time domain. In the frequency domain, coherence, gain, and phase were calculated in the very low and low
frequency bands. Results. The CV of MAP was significantly higher during intervention compared to baseline. On individual level,
coherence in the VLF band changed in 5 of 21 measurements from unreliable to reliable and in 6 of 21 measurements from reliable
to unreliable. In the LF band 1 of 21 measurements changed from unreliable to reliable and 3 of 21 measurements from reliable to
unreliable. Gain in the VLF and LF band was lower during intervention compared to baseline. Conclusions. For the ICU setting,
more attention should be paid to the exact experimental protocol, since changes in experimental settings strongly influence results
of estimation of cerebral autoregulation.
1. Introduction
Postanoxic encephalopathy is a common phenomenon after
cardiac arrest and causes high mortality and morbidity [1].
Adapting the cerebral blood flow (CBF) to the cerebral
metabolic demand improves cerebral recovery after cardiac
arrest.
Cerebral autoregulation (CA) describes the process of
cerebral vasodilation and vasoconstriction to maintain a
stable CBF over a wide range of perfusion pressures. This
adjustment of CBF to changes in cerebral perfusion pressure
is directed by central regulation-mechanisms [2, 3] and by
a local adaptation using myogenic vasoconstriction [4, 5].
In the low frequency band (LF, 0.07–0.2Hz) blood pressure
variations are provoked by sympathetic modulation of vas-
cular tone [6]. Local vascular myogenic changes in blood
pressure occur in the LF and very low frequency bands
(VLF, 0.02–0.07Hz) [7]. In the high frequency band (HF,
0.2–0.5Hz) nitric oxide (NO) affects cardiovascular variabil-
ity in animals [8]. Cerebral autoregulation is disturbed in
a large proportion of patients after cardiac arrest [9, 10].
Disturbed autoregulation in the early phase after cardiac
arrest is strongly associated with unfavourable outcome [9].
After cardiac arrest, the spontaneous variability of arterial
pressure is significantly lower compared to age- and sex-
matched control patients [11]. In addition, spontaneous vari-
ability in themean flow velocity (MFV) in themiddle cerebral
artery as measured by transcranial Doppler (TCD) is also
reduced. MFV variability restores towards normal values in
survivors after cardiac arrest, while variability continues to
decline in patients who do not survive [11].
For the estimation of dynamic CA, transfer function anal-
ysis (TFA) is considered the gold standard. TFA describes the
dynamic relationship between blood pressure (input signal)
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and CBF (output signal). This technique relies on sponta-
neous or induced fluctuations in MFV and mean arterial
pressure (MAP). Reduced variability in the input signal will
strongly reduce the reliability of the resulting output signal
[12]. Recently, a white paper was published by the Cerebral
Autoregulation Research Network (CARNet, http://www
.car-net.org) with recommendations to improve the stan-
dardization and settings for TFA applications in studies of
dynamic autoregulation [12]. Because of a lack of evidence in
thismatter, this paper could not formulate a recommendation
regarding the minimum variability of the input signal that is
required for reliable estimation of dynamic autoregulation.
As a result, low variability may not be regarded as a criterion
to reject or at least critically appraise CA data.
The main objective of our study was to determine if an
increase in variability of the blood pressure signal influences
determination of the state of autoregulation both in the time
and in the frequency domain.
2. Materials and Methods
2.1. Study. A prospective observational study was performed
at the intensive care unit (ICU) of a tertiary care university
hospital in Nijmegen, the Netherlands.
2.2. Population. We studied 13 comatose patients admitted
to the ICU after an out-of-hospital cardiac arrest. Inclusion
criteria were age ≥ 18 years and a Glasgow Coma Score
≤ 8 after return of spontaneous circulation. Patients were
included after written informed consent and approval of the
protocol by the local Institutional Review Board (document
number 2015-1567, 52259.091.15).
Exclusion criteria were an irregular heart rhythm, no
transtemporal bone window, pregnancy, thrombolytic ther-
apy, refractory cardiogenic shock, intra-aortic balloon pump,
a life expectancy ≤ 24 hours and known carotid artery
stenosis, or signs of carotid artery stenosis on physical exami-
nation or ultrasound.
2.3. Patient Management. The patients were treated accord-
ing to the local protocol as described in a previousmanuscript
[11]. In short, this included mild therapeutic hypothermia
32–34∘C for 24 hours, followed by passive rewarming to 37∘C.
All patients were sedated and sedation was stopped as soon as
the temperature reached 36∘C [11]. All patientswere intubated
and mechanically ventilated to obtain a PaO
2
> 75mmHg
and a PaCO
2
34–41mmHg [11]. An arterial catheter was
used for monitoring of arterial blood pressure (ABP) and
sampling of blood. According to this local protocol,MAPwas
maintained 80–100mmHg [11].
2.4. Data Collection. Demographic, prehospital, and clinical
data were collected. MFV in the middle cerebral artery was
measured by TCD through the temporal window with a
2-Mhz probe (Multi-Dop T Digital, Compumedics DWL,
Singen, Germany) as described in a previous manuscript
[11]. All measurements were performed by two investigators
(J.B. and C.H.). A 30-minute window of cerebral blood flow
velocity (CBFV) and ABP was simultaneously recorded on
a laptop computer and stored on a hard disk with a sample
rate of 200Hz by an A/D converter (NI USB-6211, National
Instrument, Austin, TX, USA).
2.5. Intervention. Baseline recordings of continuousABP and
CBFV were performed with the patient at rest, with the head
of bed elevated at 30 degrees. The intervention consisted of
repeated changes in the position of the bed from horizontal
to maximum 30 degrees Trendelenburg and 30 degrees anti-
Trendelenburg (period 6 minutes), thereby inducing low
frequency blood pressure fluctuations. The blood pressure
transducer was attached to the bed at right atrium level
and its position changed simultaneously with the position
of the patient. The patient was moved for 15 seconds from
Trendelenburg to non-Trendelenburg and remained in this
position for 45 seconds. A total of 3 Trendelenburg and 3 non-
Trendelenburg positions weremeasured during the 6minutes
of testing. Changes were timed and recorded. During the
measurements, PaO
2
and PaCO
2
were within normal ranges
and stable.
Measurements were performed on admission to the ICU
and at 24, 48, and 72 hours.
2.6. Data Analysis. CBFV and ABP data were analyzed
using custom-written MATLAB scripts (Matlab R2014b, The
MathWorks Inc., Massachusetts, USA), as described in a
previous manuscript [11]. From these ABP and CBFV signals,
5-minute segments of baseline and intervention data were
selected based on the least amount of artefacts [11]. MAP
and MFV were acquired by filtering ABP and CBFV with
a third-order zero phase-lag Butterworth filter with a cut-
off frequency of 0.5Hz [11]. By averaging these 5-minute
windows of the MAP andMFV signals, mean values of MAP
and MFV were acquired [11]. For transfer function analysis,
the CARNet TFA MATLAB script was used (available on
http://www.car-net.org).
To validate our analysis, an external expert (J.C.) went
through the analysis step by step to check whether this analy-
sis had been performed in agreement with the recommen-
dations in the white paper on transfer function analysis of
the International Cerebral Autoregulation Research Network
[12].
2.7. Blood Pressure Variation. Coefficient of variation (CV)
was used as a standardized measure of dispersion for both
MAP and MFV in the time domain. CV was defined as the
standard deviation of the signal divided by the mean of the
signal and was calculated from all filtered signals. This way,
the variation is expressed in percentage of the mean.
In the frequency domain, the average spectral power of
MAP and MFV was calculated as a measure of variation in
the very low (VLF, 0.02–0.07Hz) and low (LF, 0.07–0.2Hz)
frequency bands.
2.8. Cerebral Autoregulation. CA was calculated in the time
domain and frequency domain. In the time domain, CA was
calculated by themean flow velocity index (Mx) as a Pearson’s
correlation coefficient between 10-second averages of ABP
and CBFV over the 5-minute time window [13]. A cut-off
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Table 1: Clinical and laboratory data of cardiac arrest patients on admission. PEA: pulseless electrical activity; VF: ventricular fibrillation;
VT: ventricular tachycardia.
Characteristics
Age (years) 61 [50–65]
Male (n, %) 12/13 (92%)
Initial rhythm VT/VF (n, %) 12/13 (92%)
Initial rhythm PEA (n, %) 1/13 (8%)
SAPS 2 58 [42–77]
APACHE 2 27 [18–30]
pH 7.01 [6.94–7.27]
Lactate (mmol/L) 8.5 [7.0–13.3]
PaCO2 (mmHg) 7.0 [6.2–9.5]
value of 0.3 was chosen to indicate absence or presence of
autoregulation [14].
In the frequency domain, TFA was performed according
to the recommendations by the international Cerebral Auto-
regulation Research Network (CARNet) [12]. In short, the 5-
minute segments of MFV and MAP signals were resampled
to 10Hz. Both auto- and cross-spectra were estimated based
on Welch’s method using a sliding Hanning window of 100
seconds’ window length with 50% overlap. Spectral smooth-
ingwas applied by using a triangularmoving averagewindow.
Gain and phase were only calculated when coherence was
above the critical coherence threshold based on the 95%
confidence interval. The cut-off value was 0.34. The TFA
coherence, gain, and phase were calculated for the very low
(VLF, 0.02–0.07Hz) and low (LF, 0.07–0.2Hz) frequency
bands.
2.9. Statistical Analysis. Statistical analysis was performed
using GraphPad Prism version 5.0 (GraphPad Software, La
Jolla, CA). Data were checked for Gaussian distribution by
a Kolmogorov-Smirnov test. Paired, normal distributed data
were analyzedwith a paired t-test and presented asmeanwith
standard deviation. Paired non-Gaussian distributed data
were analyzed with a Wilcoxon matched-pairs signed rank
test and presented as median with 25th and 75th percentile.
A𝑝 value of<0.05was considered to indicate significance.
3. Results
3.1. Demographic and Clinical Data. We included 13 coma-
tose patients successfully resuscitated after cardiac arrest and
treated with mild therapeutic hypothermia. The median age
was 61 [50–65] years. Twelve patients had ventricular fibril-
lation (VF) or ventricular tachycardia (VT) as initial rhythm,
and 1 patient initially had a pulseless electrical activity (PEA).
Four patients died in the ICU, all because of severe postanoxic
brain damage. The clinical and laboratory data on admission
are summarized in Table 1.
3.2. Mean Arterial Blood Pressure Variation and Mean Flow
Velocity Variation in the Time Domain. Tilting of the bed
induced a significant increase in CV of MAP from 3.056 ±
1.464 at baseline to 8.238 ± 2.646 during intervention (𝑝 <
0.0001) (Figure 1). The CV of MFV after cardiac arrest
CV MAP and MFV
0
5
10
15
CV
 (%
)
I-MAP BL-MFV I-MFVBL-MAP
∗∗∗ ∗∗
Figure 1: CV of MAP and MVF after cardiac arrest in baseline
position and during intervention. BL: baseline; CV: coefficient of
variation; I: intervention; MAP: mean arterial pressure; MVF: mean
flow velocity.
was also significantly higher during the intervention (7.571
[6.124–9.176]) compared to baseline (6.090 ± 3.613) (𝑝 =
0.0028) (Figure 1).
3.3. Cerebral Autoregulation
3.3.1. Time Domain. On group level, Mx did not change
during intervention (0.5669 [0.0132–0.7712]) compared to
baseline (0.3757 ± 0.4473) (𝑝 = 0.6776) (Figure 2). On indi-
vidual level, in 9 of the 21 measurements (43%) interpretation
of the CA changed during intervention. Five measurements
changed from intact to impaired CA and 4 measurements
changed from impaired to intact CA.
3.3.2. Frequency Domain. There were no significant changes
on a group level in coherence between baseline (0.4449 ±
0.2692) and intervention (0.4313 ± 0.2702) in the VLF band
(𝑝 = 0.8281) (Figure 3). There were also no changes in
coherence in the LF band between baseline (0.3476 [0.2655–
0.6949]) and intervention (0.3043 [0.2361–0.6444]) (𝑝 =
0.3265) (Figure 4). On an individual level, in the VLF band, 5
of the 21 measurements changed from unreliable to reliable
and 6 of the 21 measurements changed from reliable to
unreliable. In the LF band 1 of the 21 measurements changed
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Figure 2: Mx after cardiac arrest in baseline position and during
intervention. Five of the 21 measurements changed from intact to
affected CA and 4 of the 21 measurements changed from affected to
intact CA. Mx: mean flow velocity index.
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Figure 3: Coherence in the VLF band. Five of the 21 measurements
changed from unreliable to reliable and 6 of the 21 measurements
changed from reliable to unreliable. VLF: very low frequency.
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Figure 4: Coherence in the LF band. One of the 21 measurements
changed from unreliable to reliable and 3 of the 21 measurements
changed from reliable to unreliable. LF: low frequency.
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Figure 5: The gain in the VLF band during intervention was lower
compared to the gain in the VLF baseline (𝑝 = 0.0058). VLF: very
low frequency.
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Figure 6: The gain in the LF band during intervention was lower
compared to the gain in the LF band baseline (𝑝 = 0.0523). LF: low
frequency.
from unreliable to reliable and 3 of the 21 measurements
changed from reliable to unreliable.
The gain in the VLF band during intervention (0.5578 ±
0.3046) was lower compared to the gain in the VLF baseline
(0.7746 ± 0.2579) (𝑝 = 0.0058) (Figure 5). The gain in
the LF band during intervention (0.9817 ± 0.4007) was
lower compared to the gain in the LF band baseline (1.075
[0.7757–1.405]) (𝑝 = 0.0523) (Figure 6).
There were no changes in phase in the VLF and LF
band during intervention (21.29 [11.73–38.64] and 14.96
[−3.546–27.16], respectively) compared to the phase in base-
line position (36.12 ± 31.01 and 12.00 [0.1032–22.62], respec-
tively) (𝑝 = 0.4548 and 0.570, respectively) (Figure 7).
4. Discussion
Amplification of blood pressure variability changed the inter-
pretation of CA as measured by Mx and TFA.This difference
in test results is not related to physiological changes in CA, as
both baseline and intervention were performed at the same
time-point after cardiac arrest. This difference in test results
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Figure 7:There were no changes in phase in theVLF and LF band during intervention compared to the phase in baseline position (𝑝 = 0.4548
and 0.570, respectively). LF: low frequency; VLF: very low frequency.
is most likely related to bias induced by very low variability in
the blood pressure andMFV signal at baseline, which renders
estimation of CA with these methods unreliable.
For the estimation of dynamic CA, TFA is considered
the gold standard. The white paper on TFA methodology
provides recommendations on the optimal cut-off values of
coherence and parameter settings [12]. No recommendations
are available for the optimal experimental or clinical protocol.
High quality of both theABP andMFV signal are essential for
reliable estimation of CA [15]. Poor quality of the temporal
bone insonation conditions or poor quality of the arterial or
MFV signal can result in considerable bias of the TFA results.
Quality of both signals was adequate in our study and did not
explain the intervention induced changes in TFA and Mx in
our population.
The optimal recording time of signals for autoregulation
to stabilize is largely unknown. Recording time for the
autoregulatory index Mx significantly influences validity of
the measurements. Mx calculated on intervals shorter than 6
minutes is at risk for changes due to insufficient stabilization
of the signal [16]. The Mx data were determined from a
5-minute time window, possibly influencing the validity of
the Mx.
Thewhite paper recommends aminimumwindow length
for TFA analysis of at least 100 seconds [12]. This is based on
the fact that window lengths shorter than 75 seconds resulted
in increased bias [12]. Recording time of the TFA signals at
baseline and during intervention in our study was sufficiently
long to avoid bias related to time restriction.
The extent to which TFA outcomes are influenced by
quality of the signals differs between different parameters. In
our study, increased variability of signals resulted in decrease
in gain in both the LF and VLF bands, whereas phase
remained stable. This is most likely related to the fact that
gain reflects the strength of the autoregulation, which may
be changed by increased amplitude of the signal. In contrast,
phase is related to velocity of dynamic changes in autoreg-
ulation. Since augmentation of the variability is unlikely to
change the timing of the arterial and cerebral pulses, phase
may remain unchanged during the intervention.
The use of the coherence function is recommended
to identify conditions where estimates of gain and phase
may not be reliable. The intervention changed the level
of coherence from unreliable to reliable in a substantial
portion of patients, but the reverse (change from reliable to
unreliable) occurred in a similar proportion of patients. Since
the variability was extremely low, the input signal may have
been too low for adequate determination of TFA coherence
at baseline.
This was supported by visual inspection of the raw data
and linking this with individual outcomes of TFA. Visual
inspection of the raw signals can easily identify whether
oscillations inMAP and CBFV are present and whether these
oscillations are temporally related. In the few patients who
showed variability in bothMAP andCBFV, the results of TFA
appeared reliable, with higher phase values in VLF than in LF
and lower gain values in VLF than in LF. In contrast, when
TFA was performed in patients with low MAP variability,
these normal patterns were not observed, even if coherence
was above the threshold.
In an earlier study we proved that the spontaneous
variability of the MAP remained low during the entire study
period after cardiac arrest [11]. In the current study we
demonstrated a significant increase in CV of MAP during
tilting of the bed compared to the resting position. Previ-
ous literature showed an improvement of reproducibility of
the autoregulation coefficients by inducing blood pressure
variability due to a sit-to-stand manoeuvre [17, 18]. However,
those manoeuvres lead to consistent oscillatory changes that
enhance reliability, in contrast with bed tilting.
This study has a number of limitations. We performed an
observational study in a relatively small population. Tilting
of the bed may result in changes in quality of the recorded
signal, such as loss of signal, motion artefacts, and baseline
drifts. Reanalysis of the raw signals however was carefully
performed by an independent expert (J.C.), using only good
quality signals and verifying correct TFA settings, but this
did not alter the outcome. Changes in the bed position may
influence the pressure in the veins draining the cerebral
venous blood. These changes in venous outflow pressure
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may influence cerebral perfusion and thus the validity of the
autoregulation measurements.
5. Conclusions
The white paper on TFA methodology currently provides no
recommendations about minimal necessary blood pressure
variation to perform a reliable TFA. Given the results of
this study, addition of minimal necessary variation of input
signals to the white paper on TFAmethodologymay improve
the validity of TFAmeasurements. For the ICU setting, more
attention should be paid to the exact experimental protocol,
since changes in experimental settings strongly influence
results of estimation of CA. The optimal level of variation
of the signals will be difficult to establish because of the lack
of golden standards of autoregulation for comparison of the
results. Computer modelling may be helpful to establish the
effects of changes in different parameters on the measure-
ments of autoregulation.
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